newsfilter
← Latest News
GlobeNewswire·

Treace to Report First Quarter 2026 Financial Results on May 8, 2026

  • Treace Medical Concepts (NASDAQ: TMCI) will announce first quarter 2026 financial results before trading begins on Friday, May 8, 2026.
  • Company management will host a conference call starting at 8:00 am ET to discuss the financial results.
  • Investors can register online to receive dial-in numbers & pins, or listen via a live & archived webcast on the investor relations website.
  • Treace is a medical technology company focused on surgical treatment for bunions & related midfoot deformities affecting approximately 67 million Americans.
  • The company's core offerings include the Lapiplasty 3D Bunion Correction System, Adductoplasty Midfoot Correction System, Nanoplasty, Percuplasty, & SpeedMTP systems.
  • Treace is expanding its SpeedPlate rapid compression implant platform & providing IntelliGuide patient-specific pre-op planning technology.
  • Mark L. Hair serves as Chief Financial Officer for Treace Medical Concepts.